Literature DB >> 10337998

Deletion mapping of the tumor suppressor locus involved in colorectal cancer on chromosome band 8p21.

F Lerebours1, S Olschwang, B Thuille, A Schmitz, P Fouchet, P Laurent-Puig, F Boman, J F Fléjou, G Monges, F Paraf, P Bedossa, J C Sabourin, R J Salmon, R Parc, G Thomas.   

Abstract

Several somatic genetic alterations have been described in colorectal carcinoma (CRC). Recurrent chromosomal deletions have suggested the presence of tumor suppressor genes (TSG) specifically involved in colorectal carcinogenesis. For one of them, two non-overlapping regions have been proposed on the short arm of chromosome 8, encompassing the LPL and NEFL genes. The short arm of chromosome 8 has been extensively studied in colorectal cancer and in other cancer types. Both regions have been reported as candidate loci for a TSG. In order to delineate a reliable region of deletional overlap on chromosome arm 8p in CRC, a series of 365 CRC samples was selected for the absence of microsatellite instability (RER, replication error); tumor and normal matched DNAs were studied for 54 microsatellite polymorphisms distributed on 8p using multiplex-PCR amplification. After purification of tumor nuclei by flow cytometry based on either the abnormal DNA index or the presence of a high expression of cytokeratin, complete allelic losses on 8p were observed in 48% of cases. Measurement of the DNA index showed that 88% of RER tumors were hyperploid. Complete allelic losses of only part of the short arm were observed on 26 occasions. These data allowed us to define a 1 cM interval of common deletion, flanked by the loci D8S1771 and NEFL, where a putative TSG may be localized.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337998     DOI: 10.1002/(sici)1098-2264(199906)25:2<147::aid-gcc10>3.0.co;2-z

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Authors:  Mario Capasso; Sharon Diskin; Flora Cimmino; Giovanni Acierno; Francesca Totaro; Giuseppe Petrosino; Lucia Pezone; Maura Diamond; Lee McDaniel; Hakon Hakonarson; Achille Iolascon; Marcella Devoto; John M Maris
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

2.  Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases.

Authors:  J C Weber; A Schneider; S Rohr; H Nakano; P Bachellier; A Méchine; G Hamel; M Kanor; M P Chenard; M P Gaub; P Oudet; C Meyer; D Jaeck
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

3.  NEFL mRNA expression level is a prognostic factor for early-stage breast cancer patients.

Authors:  Xiao-Qing Li; Lin Li; Chun-Hua Xiao; Yu-Mei Feng
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

4.  Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex.

Authors:  Jacob R Manjarrez; Liang Sun; Thomas Prince; Robert L Matts
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

5.  Association of NEFL Gene Polymorphisms with Wilms' Tumor Susceptibility in Chinese Children.

Authors:  Wei Jia; Jinhong Zhu; Wen Fu; Shibo Zhu; Fuming Deng; Huimin Xia; Guo-Chang Liu; Jing He
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.